Revenue fell 21% year-over-year to MUS$529,275, with a net loss of MUS$15,213 due to lower prices, volumes, and higher costs. The US remains the main market, and the company faces ongoing biological, environmental, and financial risks.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.